Notch Therapeutics


Notch is an immune cell therapy company developing a next-generation pipeline of off-the-shelf, universally compatible, genetically tailored T cell therapeutics derived from renewable stem cell sources for the treatment of high-impact diseases, with an initial focus on cancer.





David Main
President and CEO

David Main

Kamran Alam
EVP, Finance and CFO
Chris Bond
SVP, Research & Early Development
Emily Titus
VP, Process Sciences
Marianne Schovsbo
Executive Director, Project Management
Steven Woodside
Senior Director, Engineering
Liz Csaszar
Director, Manufacturing
Timothy Key
Director, Business Development
Cari Barthe
Director, People & Culture, US
Kristi Steed
Director, People And Culture
Kyle Walters
Director, Project Management
Amanda Auyeung
Scientist I, Preclinical Pharmacology
Michael Hunter Cadell
Senior Research Associate
Omar Subedar
Senior Research Associate
Sommer Kanoe Apelu
Senior Research Associate
Yue Zhang-Wong
Senior Research Associate
Elisa Martinez
Scientist I, Ipsc Differentiation
Seungmi Yoo
Senior Scientist
Justin Yoo
Senior Scientist
Valerie Wall
Senior Scientist
Laura Prochazka
Scientist II Cell Engineering / Synthetic Biology
Vignesh Janardhanam
Research Associate Ii, Cancer Biology & Translational Sciences